Travoprost Intraocular Implant in Conjunction With Cataract Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Ocular Hypertension
Related studies linked through entity extraction aliases.
Study of Safety and Efficacy of H-1337 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
- Status
- COMPLETED
- Phase
- PHASE2
Direct Selective Laser Trabeculoplasty in Ethnic Chinese Population
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Dorzolamide+Timolol Multidose Preservative-free vs Dorzolamida+Timolol BAK Preserved Efficacy and Safety
- Status
- COMPLETED
- Phase
- PHASE4
Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial
- Status
- RECRUITING
- Phase
- NA
Safety and Tolerability Study of QLS-101 in Adolescents With Sturge-Weber Syndrome (SWS)-Related Glaucoma Due to Elevated Episcleral Venous Pressure (EVP)
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Investigate the Effect of IOP-lowering With TO-O-1001 Eye Drops in Healthy Subjects and in Patients With Open-Angle Glaucoma or Ocular Hypertension
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
- Status
- RECRUITING
- Phase
- PHASE3
Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous Patients
- Status
- COMPLETED
- Phase
- PHASE3
Safety Assessment of T4090 Eye Drops in Ocular Hypertensive or Glaucomatous Patients.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)
- Status
- COMPLETED
- Phase
- PHASE2
Study of a Latanoprost Ocular Implant for Treatment of Open Angle Glaucoma or Ocular Hypertension.
- Status
- COMPLETED
- Phase
- PHASE1
24-hour Efficacy and Tolerability of the Tafluprost-timolol Fixed Association Without Preservatives in Glaucomatous or Ocular Hypertensive Patients Already Treated With Latanoprost Preserved With BAK. A Prospective, Open Study of 3 Months Duration.
- Status
- UNKNOWN
- Phase
- PHASE4
Study in Prostaglandin Associated Peri-orbitopathy Switching From Prostaglandin Monotherapy to Omidenepag Isopropyl
- Status
- UNKNOWN
- Phase
- PHASE4
Use of Nanodropper vs. Standard Eyedropper in Patients With Glaucoma and Ocular Hypertension
- Status
- UNKNOWN
- Phase
- NA
Efficacy of the Nanodropper Device on Intraocular Pressure in Patients With Glaucoma
- Status
- TERMINATED
- Phase
- NA
Safety and Effectiveness of Drop-free Small Incision Cataract Surgery
- Status
- UNKNOWN
- Phase
- NA
PSLT Compared to Prostaglandin Analogue Eye Drops
- Status
- UNKNOWN
- Phase
- NA
Evaluation of Nanodropper-mediated Microdrops vs. Standard Drops of 0.5% Timolol Maleate in Glaucoma Patients
- Status
- COMPLETED
- Phase
- NA
Optimal Treatment Protocol for Selective Laser Trabeculoplasty - Repeat Trial
- Status
- ENROLLING_BY_INVITATION
- Phase
- NA